CryoLife spins off fibrin sealant development company
This article was originally published in Clinica
Executive Summary
CryoLife has set up a separate company, AuraZyme Pharmaceuticals, to speed up development of its light-activated fibrin sealant, FibRx, without putting too much strain on the company balance sheet.